A study of alternate biomarkers in HIV disease and evaluating their efficacy in predicting T CD4+ cell counts and disease progression in resource poor settings in highly active antiretroviral therapy (HAART) era

Journal of Clinical and Diagnostic Research

Volumn 7, Issue 7, 2013, Pages 1332-1335

  Ramana, K V ^a   Sabitha, V ^b   Rao, Ratna ^a  

^a Apollo Health City ^*  (India)

^b Department of Biochemistry   (India)

Author keywords

Alternate biomarkers; HAART; Human immunodeficiency virus (HIV)

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN;

ABSOLUTE EOSINOPHILIC COUNT; ADULT; AGED; ARTICLE; BIOLOGICAL MONITORING; CD4 LYMPHOCYTE COUNT; CD8 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CLINICAL EFFECTIVENESS; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE MARKER; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEALTH CARE SYSTEM; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE DIFFERENTIAL COUNT; LOWEST INCOME GROUP; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; TOTAL LYMPHOCYTE COUNT; TREATMENT OUTCOME;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84879965652     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2013/5306.3138     Document Type: Article

References (26)

1. Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for AIDS. Science. 1983; 220: 868-871.
2. UNAIDS Epidemic update 2007. http://data.unaids.org/pub/PressRelease/2007/070706_indiapressrelease_en.pdf
3. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA et al. Declining morbidity and mortality among patients with advanced HIV infection. HIV outpatient study investigators. N Engl J Med. 1998; 338:853-60.
4. Vajpayee M, Mohan T. Current practices in laboratory monitoring of HIV infection. Indian J Med Res. 2011; 134(6): 801-22. doi: 10.4103/0971-5916.92627
5. NACO (2006). HIV/AIDS Epidemiological Surveillance and Estimation Report for the Year 2005. New Delhi. National AIDS Control Organisation. http://www.aidsportal.org/repos/fnlapil06rprt.pdf
6. Ramana KV, Jagadeeswhwara chary, Sabitha V, SK Mohanty, Ratna Rao. Role of Hematological and Alternate Markers in Human Immunodeficiency Virus Disease Progression. Am Med J. 2010; 1(2): 84-87.
7. Baveewo S, Ssali F, Karamagi C, Kalyango JN, Hahn JA, Ekoru K, et al. Validation of World Health Organisation HIV/AIDS Clinical Staging in Predicting Initiation of Antiretroviral Therapy and Clinical Predictors of Low CD4 Cell Count in Uganda. PLoS One. 2011 May 12; 6(5):e19089. doi: 10.1371/journal.pone.0019089.
8. WHO: Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach - 2003 revision (Monograph online). Switzerland: WHO press; 2004. Available from: http://www.who.inUhiv/pub/prev3areieniarvrevision2003en.pdf.
9. Sourav Sen., Akshat Vyas, Sunil Sanghi, K Shanmuganandan, RM Gupta, Ketoki Kapila, et al. Correlation of CD4+ T cell Count with Total Lymphocyte Count, Haemoglobin and Erythrocyte Sedimentation Rate Levels in Human Immunodeficiency Virus Type-l Disease. MJAFI. 2011; 67: 15-20.
10. Azzoni L, Foulkes AS, Liu Y, Li X, Johnson M, Smith C, et al. Prioritizing CD4 Count Monitoring in Response to ART in Resource- Constrained Settings: A Retrospective Application of Prediction-Based Classification. PLoS Med 2012; 9(4): e1001207. doi:10.1371/journal. pmed.1001207.
11. Boulware DR, Meya DB, Bergemann TL, Wiesner DL, Rhein J, Musubire A, et al. Clinical Features and Serum Biomarkers in HIV Immune Reconstitution Inflammatory Syndrome after Cryptococcal Meningitis: A Prospective Cohort Study. PLoS Med 2010; 7(12): e1000-384. doi:10.1371/journal.pmed.1000384.
12. French MA. Immune reconstitution inflammatory syndrome: immune restoration disease 20 years on. Med J Aust. 2012 Mar 19; 196(5): 318-21.
13. Brentlinger PE, Torres JV, Martínez PM, Ghee A, Lujan J, Bastos R, et al. Clinical Staging of HIV-Related Illness in Mozambique: Performance of Non physician Clinicians Based on Direct Observation of Clinical Care and Implications for Health Worker Training. J Acquir Immune Defic Syndr. 2010; 55:351-55.
14. Cohen AJ, Steigbigel RT. Eosinophilia in Patients Infected with Human Immunodeficiency Virus. J Infect Dis. 1996; 174: 615-18.
15. Ndakotsu MA, Salawu L, Durosinmi MA. Relation between erythrocyte sedimentation rate, clinical and immune status in HIV-infected patients. Niger J Med. 2009; 18(2):208-10. [PubMed: 19630332]
16. Morpeth SC, Crump JA, Shao HJ, Ramadhani HO, Kisenge PR, Moylan CA, et al. Predicting CD4 lymphocyte count <200 cells/ mm(3) in an HIV type 1-infected African population. AIDS Res Hum Retroviruses. 2007; 23(10):1230-6. [PubMed: 17961109].
17. Lowe DM. The Erythrocyte sedimentation rate in HIV: a neglected Parameter? AIDS. 2010 Nov 27; 24(18):2773-5. doi: 10.1097/ QAD.0b013e32833ef5d7.
18. Peters PJ, Zulu I, Kancheya NG, Lakhi S, Chomba E, Vwalika C, et al. Rwanda Zambia HIV Research Group. Modified Kigali combined staging predicts risk of mortality in HIV-infected adults in Lusaka, Zambia. AIDS Res Hum Retroviruses. 2008; 24(7):919-24. [PubMed: 18593343].
19. Owiredu WK, Quaye L, Amidu N, Addai-Mensah O. Prevalence of anaemia and immunological markers among Ghanaian HAART-naïve HIV-patients and those on HAART. Afr Health Sci. 2011 Mar;11(1):2-15.
20. Wisaksana R, Sumantri R, Indrati AR, Zwitser A, Jusuf H, de Mast Q, et al.: Anemia and iron homeostasis in a cohort of HIV-infected patients in Indonesia. BMC Infect Dis. 2011; 11:213.
21. Mata-Marín JA, Gaytán-Martínez JE, Martínez-Martínez RE, Arroyo- Anduiza CI, Fuentes-Allen JL, Casarrubias-Ramirez M. Risk factors and correlates for anemia in HIV treatment-naïve infected patients: a cross-sectional analytical study. BMC Res Notes. 2010 Aug 20; 3:230. doi: 10.1186/1756-0500-3-230.
22. Suresh Venkata Satya Attili, VP Singh, Madhukar Rai, Datla Vivekananda Varma, K Gulati, Shyam Sundar. Hematological profile of HIV patients in relation to immune status - a hospital-based cohort from Varanasi, North India. Turk J Hematol. 2008; 25:13-19.
23. Miiro G, Nakubulwa S, Watera C, Munderi P, Floyd S, Grosskurth H. Evaluation of affordable screening markers to detect CD4+ T cell counts below 200 cells/μl among HIV-1-infected Ugandan adults. Trop Med Int Health. 2010 Apr; 15(4):396-404. doi: 10.1111/j.1365- 3156.2010.02471.x. Epub 2010 Feb 17.
24. Jafari S, Rasoolinejad M, Emadi Kouchak H, Mokarami F. The relationship between total lymphocyte count and CD4 count in patients infected with HIV. Tehran Medical Journal. 2009;67(7): 477-82.
25. de Jong MA, Wisaksana R, Meijerink H, Indrati A, van de Ven AJ, Alisjahbana B et al. Total lymphocyte count is a reliable surrogate marker for CD4 cell counts after the first year of antiretroviral therapy: data from an Indonesian cohort study. Trop Med Int Health. 2012 May; 17(5):581-3. doi: 10.1111/j.1365-3156.2012.02961.x. Epub 2012 Feb 26.
26. Oudenhoven HP, Meijerink H, Wisaksana R, Oetojo S, Indrati A, van der Ven AJ, et al. Total lymphocyte count is a good marker for HIV-related mortality and can be used as a tool for starting HIV treatment in a resource-limited setting. Trop Med Int Health. 2011 Nov; 16(11):1372-9. doi: 10.1111/j.1365-3156.2011.02870.x. Epub 2011 Sep 1.